Autoimmune Diseases / 2011 / Article / Tab 2

Research Article

Long-Term Respiratory Muscle Endurance Training in Patients with Myasthenia Gravis: First Results after Four Months of Training

Table 2

Lung function data.

PatientVC (L)FEV1 (L)PEF (L s−1)MVV (L min−1) (kPa)
BP1P4BP1P4BP1P4BP1P4BP1P4

13.84.14.23.13.33.97.16.27.61421501339.19.49.5
23.93.84.03.13.13.18.68.08.41381311889.510.911.4
33.13.43.32.32.62.44.55.14.77473845.66.97.0
43.73.73.62.93.22.97.69.49.01301521448.98.98.3
53.73.43.52.82.52.57.77.88.91241211144.35.35.3
63.93.64.42.72.63.54.75.37.273891056.65.86.3
72.82.72.62.12.12.04.95.14.49191975.66.65.1
84.64.74.43.12.92.97.07.47.41621541558.19.09.3
92.62.62.82.12.42.34.64.45.17675815.95.14.6
102.72.93.51.92.22.57.17.67.59492905.95.86.1

Mean3.53.53.62.62.72.86.46.67.01101131196.77.17.1
SEM0.200.200.200.150.130.180.490.520.5310.310.311.10.570.670.75

VC; vital capacity; FEV1; forced expiratory volume in 1 s; PEF; peak expiratory flow; MVV; maximal voluntary ventilation; ; maximal inspiratory pressure. B; baseline values; P1; posttraining test after 4 weeks of training (phase 1); P4; posttraining test after 4 months of training (phase 2).